Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs71429042 | chr14:74625274 | C/T | 2.8E-10 | 176 | 25.4 | 27.27 | 7.4 | KM Plot |
PCPG | rs71430338 | chr2:242528640 | G/A | 5.87E-5 | 173 | 25.87 | 29.57 | 20.2 | KM Plot |
PCPG | rs71430376 | chr2:242597554 | A/G | 1.15E-10 | 170 | 25.4 | 19.75 | 10.3 | KM Plot |
PCPG | rs71439112 | chr2:24310967 | T/C | 0.00011 | 178 | 25.28 | 26.92 | 17.43 | KM Plot |
PCPG | rs71439113 | chr2:24310979 | C/T | 0.00011 | 178 | 25.28 | 26.92 | 17.43 | KM Plot |
PCPG | rs71439115 | chr2:24340461 | C/T | 0.000114 | 177 | 25.4 | 26.92 | 17.43 | KM Plot |
PCPG | rs71449181 | chr14:74658789 | AC/A | 1.82E-5 | 178 | 25.4 | 27.75 | 10.3 | KM Plot |
PCPG | rs71460951 | chr14:74529511 | GA/G | 0.000237 | 174 | 25.28 | 27.43 | 10.43 | KM Plot |
PCPG | rs71465883 | chr12:113579086 | G/T | 0.000268 | 171 | 25.17 | 25.02 | 39.12 | KM Plot |
PCPG | rs71558287 | chr6:157167285 | T/TTTTG | 0.000238 | 177 | 25.17 | 23.42 | 43 | KM Plot |
PCPG | rs71617204 | chr3:53042951 | G/A | 6.09E-6 | 177 | 25.28 | 26.57 | 11.78 | KM Plot |
PCPG | rs71644616 | chr1:40503970 | T/G | 2.63E-6 | 174 | 24.85 | 24.88 | 37.18 | KM Plot |
PCPG | rs71644617 | chr1:40511267 | G/A | 3.3E-6 | 170 | 25 | 25.53 | 37.18 | KM Plot |
PCPG | rs71644619 | chr1:40518103 | G/A | 0.000336 | 175 | 25 | 27.27 | 25.17 | KM Plot |
PCPG | rs71708200 | chr16:90112506 | TCAA/T | 9.89E-9 | 174 | 25.87 | 20.2 | 6.62 | KM Plot |